{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:01:51Z","timestamp":1773961311015,"version":"3.50.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,6]]},"abstract":"<jats:sec>\n            <jats:title>Backgrounds:<\/jats:title>\n            <jats:p>Myasthenia Gravis (MG), a chronic neuromuscular junction disorder, emerged as one of the serious side effects of the Coronavirus Disease 2019 (COVID-19) vaccination. We aimed to summarize the findings of studies on the clinical features and outcomes of COVID-19 vaccination-associated MG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We performed a systematic search on 3 databases, Medline, Embase, and Scopus, using the query \u201cCOVID-19 vaccine\u201d and \u201cMyasthenia Gravis.\u201d Patients\u2019 data, including clinical data, MG subtype, vaccine type, and vaccine dose number, were extracted from the eligible studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 20 COVID-19 vaccination-related MGs have been reported worldwide. The median (interquartile range) age was 64 (51, 75) years; 85% (17\/20) of them were male, and 70% (14\/20) of patients had received messenger RNA-based vaccines. The most common symptoms, in order of frequency, were binocular diplopia (8\/11) and ptosis (4\/11); the median (interquartile range) time from vaccine to MG symptoms was 6 (2, 7.5) days. Repetitive nerve stimulation showed abnormal decrement in 85% (11\/13) of patients, and all 4 patients getting single-fiber electromyography showed an abnormal finding. Nine out of twelve patients with data on clinical outcomes experienced partial\/complete improvement of symptoms within 1 month.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>MG cases after the COVID-19 vaccine are more likely to occur among males and adults older than 50 years. Our pooled cohort data suggest MG symptoms appear within 2 weeks after receiving the vaccine. The presenting symptoms in MG cases associated with COVID-19 vaccine are possibly similar to non-vaccination related MGs. Most patients are expected to experience partial\/complete improvement within 1 month.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034890","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:07:34Z","timestamp":1696594054000},"page":"e34890","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-7125","authenticated-orcid":false,"given":"Amir Hossein","family":"Tayebi","sequence":"first","affiliation":[{"name":"Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parham","family":"Samimisedeh","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmira","family":"Jafari Afshar","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aryan","family":"Ayati","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaheh","family":"Ghalehnovi","sequence":"additional","affiliation":[{"name":"Razi Vaccine and Serum Research Institute, Karaj, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laleh","family":"Foroutani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Abbasi Khoshsirat","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shahid Rajaei Hospital, Alborz University of Medical Sciences, Karaj, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-0782","authenticated-orcid":false,"given":"Hadith","family":"Rastad","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1473-3099(22)00414-5","article-title":"COVID-19 vaccinations for children.","volume":"22","author":"Mariatulqabtiah","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"733418","DOI":"10.3389\/fimmu.2021.733418","article-title":"To be or not to be vaccinated: that is a question in myasthenia gravis.","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/jmri.28268","article-title":"Cardiac MRI findings in COVID-19 vaccine-related myocarditis: a pooled analysis of 468 patients.","volume":"56","author":"Samimisedeh","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e6505","DOI":"10.1002\/ccr3.6505","article-title":"Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID-19 AstraZeneca vaccination: a case report.","volume":"10","author":"Haj Mohamad Ebrahim Ketabforoush","year":"2022","journal-title":"Clin Case Rep"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-Mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination.","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"key":"R7-20250504","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"R8-20250504","first-page":"e27213","article-title":"New-Onset ocular myasthenia gravis after booster dose of COVID-19 vaccine.","volume":"14","author":"Abicic","year":"2022","journal-title":"Cureus"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"215013272110519","DOI":"10.1177\/21501327211051933","article-title":"A case of COVID-19 vaccine associated new diagnosis Myasthenia Gravis.","volume":"12","author":"Chavez","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"R10-20250504","first-page":"003439","article-title":"Myasthenia gravis presenting after administration of the mRNA-1273 vaccine.","volume":"9","author":"Hoshina","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"101620","DOI":"10.1016\/j.ajoc.2022.101620","article-title":"Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: a case report.","volume":"27","author":"Kang","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.3346\/jkms.2022.37.e50","article-title":"Early-onset myasthenia gravis following COVID-19 vaccination.","volume":"37","author":"Lee","year":"2022","journal-title":"J Korean Med Sci"},{"key":"R13-20250504","first-page":"e176","article-title":"New-onset myasthenia gravis confirmed by electrodiagnostic studies after a third dose of SARS-CoV-2 mRNA-1273 vaccine: a case report.","volume":"101","author":"Slavin","year":"2022","journal-title":"Am J Phys Med Rehabil"},{"key":"R14-20250504","first-page":"1","article-title":"Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine.","author":"Maher","year":"2022","journal-title":"Orbit"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13760-021-01612-6","article-title":"Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.","volume":"121","author":"Galassi","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1007\/s10072-022-06284-5","article-title":"New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series.","volume":"43","author":"Fanella","year":"2022","journal-title":"Neurol Sci"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.nmd.2022.09.001","article-title":"SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature.","volume":"32","author":"Ramdas","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.26328","article-title":"New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette-Guerin treatment for bladder cancer: a case study.","volume":"59","author":"Davalos","year":"2019","journal-title":"Muscle Nerve"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12883-018-1233-y","article-title":"Myasthenia gravis following human papillomavirus vaccination: a case report.","volume":"18","author":"Chung","year":"2018","journal-title":"BMC Neurol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e8757","DOI":"10.1097\/MD.0000000000008757","article-title":"New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: a case report and literature review.","volume":"96","author":"Takizawa","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2010.02.016","article-title":"Neuromuscular disorders associated with Hepatitis B vaccination.","volume":"292","author":"St\u00fcbgen","year":"2010","journal-title":"J Neurol Sci"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"107562","DOI":"10.1016\/j.ijscr.2022.107562","article-title":"Wide resection as a solution to excruciating pain in intraneural hemangioma: follow-up of a previously published case report.","volume":"98","author":"Zargarbashi","year":"2022","journal-title":"Int J Surg Case Rep"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4103\/0301-4738.145987","article-title":"Ocular myasthenia gravis: a review.","volume":"62","author":"Nair","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/014107680710000607","article-title":"The Miracle at St Alfege\u2019s: seventy years on.","volume":"100","author":"O\u2019Brien","year":"2007","journal-title":"J R Soc Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0003-4975(03)01139-1","article-title":"Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis.","volume":"76","author":"L\u00f3pez-Cano","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01215447","article-title":"Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.","volume":"84","author":"Sommer","year":"1993","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet Lond Engl"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:05:35Z","timestamp":1746327935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":26,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034890","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]}}}